BRCA1 cancer gene plays pivotal role in DNA control complex

July 20, 2000

During the last decade, researchers have been able to confidently link mutations in the BRCA1 gene to familial breast and ovarian cancers. The actual mechanism involved, however, has eluded them. What role does BRCA1 play in health, and how do specific flaws in the gene lead to cancer?

In the July 21 issue of Cell, scientists at The Wistar Institute report that the BRCA1 protein lies at the catalytic heart of a vital DNA control complex. The complex is responsible for coordinating physical access to DNA by the cellular machinery that transcribes genes. Mutant BRCA1 would interfere with the function of the complex, so that critical genes could be inappropriately activated or inactivated. Control errors of this kind can convert a normal cell to a cancerous one.

"It may be that the entire mystery of how problems with BRCA1 lead to cancer can be explained by looking at how specific mutations interfere with the DNA control complex within which we find BRCA1," says Ramin Shiekhattar, Ph.D., an assistant professor at The Wistar Institute and senior author on the study. "Also, other proteins in the complex may themselves prove useful as screening tools for predisposition to breast and ovarian cancers."

DNA, in the form of a double helix, is a long molecular strand of genetic instructions stored in the nucleus of every cell. To keep order, nature has developed a method of tightly packaging the DNA to make genes inaccessible for transcription. The DNA wraps around small proteins called histones and then further coils into a higher order structure called chromatin. Chromatin forms into chromosomes, of which humans have 23 pairs in each cell.

The DNA control complex that incorporates BRCA1 is called SWI/SNF. SWI/SNF's role is to remodel chromatin - by uncoiling it or otherwise reshaping it - to allow the cell's transcription machinery access to the DNA. Control complexes like SWI/SNF are crucial to maintaining the orderly life of a normal cell. Estimates are that only a tenth of human genes are actively expressed at any given time, and each cell type expresses its genes in signature ways.

"In essence, these complexes loosen or unwrap the DNA to allow different cellular processes access to the genes," Shiekhattar says. "What we found was that BRCA1 is associated with one of these complexes that unpackages DNA."

The protein in the SWI/SNF complex that BRCA1 directly interacts with is called BRG1. Of the 18 proteins that constitute SWI/SNF, BRG1 is thought to be the active center of the complex with the other proteins supporting its function in different ways.

"BRG1 itself is interesting to us, because mutations in BRG1, like mutations in BRCA1, may lead to cancer," Shiekhattar notes. "Mutations in BRCA1 and another gene, BRCA2, have been linked to a high percentage of familial breast and ovarian cancers, but these represent only a small percentage - perhaps 5 percent - of these cancers overall. It may be that mutations in SWI/SNF complex proteins - BRG1 in particular - account for the unexplained majority of these cancers."

Additionally, when Shiekhattar and his team looked to see what part of BRCA1 interacted with BRG1, they found the relevant region of the protein corresponded to a stretch of the BRCA1 gene called exon 11 - a portion of the gene in which a high number of cancer-linked mutations have been found. This observation tends to confirm the significance of the findings linking BRCA1 to BRG1 and the larger SWI/SNF complex. Also, most if not all of the BRCA1 found in cells occurs in the SWI/SNF complex, suggesting the primacy of this role for BRCA1.
-end-
Daniel A. Bochar, Ph.D., is first author on the Cell paper. The other Wistar coauthors are Hideo Beniya, Ph.D., and Alexander Kinev, Ph.D. Additional coauthors are William S. Lane of Harvard University; Yutong Xue and Weidong Wang of the National Institutes of Health; and Lai Wang and Fatah Kashanchi of the UMDNJ-New Jersey Medical School. Funding for the work was provided by The W.W. Smith Charitable Trust.

The Wistar Institute is an independent nonprofit biomedical research institution dedicated to discovering the basic mechanisms underlying major diseases, including cancer and AIDS, and to developing fundamentally new strategies to prevent or treat them. The Institute is a National Cancer Institute-designated Cancer Center - one of the nation's first, funded continuously since 1968, and one of only ten focused on basic research. Founded in 1892, Wistar was the first institution of its kind devoted to medical research and training in the nation. News releases from The Wistar Institute are available to reporters by direct e-mail, fax, or U.S. mail upon request. They are also posted electronically to Wistar's home page (http://www.wistar.upenn.edu ) and to EurekAlert! (http://www.eurekalert.org ), an Internet resource sponsored by the American Association for the Advancement of Science.

The Wistar Institute

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.